Rheumatology Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Rheumatology stocks.

Rheumatology Stocks Recent News

Date Stock Title
May 15 KYTX Kyverna Therapeutics reports Q1 GAAP EPS of -$1.12
May 14 UBX Unity Biotechnology GAAP EPS of -$0.34
May 14 UBX UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
May 14 KYTX Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
May 13 XGN Exagen, Inc. (XGN) Q1 2024 Earnings Call Transcript
May 13 VIRI Virios Therapeutics, Inc. (NASDAQ:VIRI) Q1 2024 Earnings Call Transcript
May 13 PETQ PetIQ, Inc. (NASDAQ:PETQ) Q1 2024 Earnings Call Transcript
May 13 XGN Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
May 13 XGN Exagen beats top-line and bottom-line estimates; raises FY24 outlook
May 13 XGN Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
May 13 VIRI VIRI: Results for Phase 2 Long COVID Trial Expected in 2H24…
May 12 MLTX MoonLake Immunotherapeutics' Competitive Edge In Autoimmune Market Expansion
May 12 VIRI Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call Transcript
May 11 PETQ PetIQ, Inc. (PETQ) Q1 2024 Earnings Call Transcript
May 11 PETQ PetIQ, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 10 PETQ PetIQ Inc (PETQ) Surpasses Q1 Revenue and Earnings Expectations, Raises 2024 Outlook
May 10 PETQ PetIQ First Quarter 2024 Earnings: EPS: US$0.51 (vs US$0.33 in 1Q 2023)
May 9 ECOR electroCore, Inc. (NASDAQ:ECOR) Q1 2024 Earnings Call Transcript
May 9 VIRI Virios Therapeutics GAAP EPS of -$0.07 misses by $0.03
May 9 VIRI Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Rheumatology

Rheumatology (Greek ῥεῦμα, rheûma, flowing current) is a branch of medicine devoted to the diagnosis and therapy of rheumatic diseases. Physicians who have undergone formal training in rheumatology are called rheumatologists. Rheumatologists deal mainly with immune-mediated disorders of the musculoskeletal system, soft tissues, autoimmune diseases, vasculitides, and heritable connective tissue disorders.
Many of these diseases are now known to be disorders of the immune system. Rheumatology is considered to be the study and practice of medical immunology.
Beginning in the 2000s, the incorporation of drugs called the biologics (which include inhibitors of TNF-alpha, certain interleukins, and the JAK-STAT signaling pathway) into standards of care is one of the paramount developments in modern rheumatology.

Browse All Tags